Advisory Services Network’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.6M Buy
50,669
+108
+0.2% +$109K 0.62% 15
2025
Q4
$54.3M Sell
50,561
-372
-0.7% -$356K 0.77% 13
2025
Q3
$38.9M Buy
50,933
+2,370
+5% +$1.76M 0.57% 19
2025
Q2
$35.9M Buy
48,563
+1,351
+3% +$1.05M 0.58% 18
2025
Q1
$39M Sell
47,212
-1,383
-3% -$1.15M 0.75% 12
2024
Q4
$37.5M Sell
48,595
-978
-2% -$810K 0.7% 15
2024
Q3
$44.9M Hold
49,573
0.93% 10
2024
Q2
$44.9M Buy
49,573
+4,045
+9% +$3.24M 0.93% 10
2024
Q1
$35.4M Buy
45,528
+2,225
+5% +$1.58M 0.79% 11
2023
Q4
$25.2M Buy
43,303
+2,641
+6% +$1.54M 0.62% 16
2023
Q3
$21.8M Sell
40,662
-122
-0.3% -$62.9K 0.59% 20
2023
Q2
$19.1M Sell
40,784
-7,228
-15% -$3.03M 0.51% 24
2023
Q1
$16.5M Buy
48,012
+1,972
+4% +$665K 0.46% 29
2022
Q4
$16.8M Buy
46,040
+2,080
+5% +$737K 0.52% 23
2022
Q3
$14.2M Buy
43,960
+1,236
+3% +$392K 0.5% 27
2022
Q2
$13.8M Buy
42,724
+11,024
+35% +$3.31M 0.47% 30
2022
Q1
$9.08M Sell
31,700
-8,483
-21% -$2.18M 0.27% 76
2021
Q4
$11.1M Buy
40,183
+4,050
+11% +$1.03M 0.32% 61
2021
Q3
$8.35M Buy
36,133
+1,972
+6% +$487K 0.27% 75
2021
Q2
$7.84M Buy
34,161
+2,816
+9% +$566K 0.25% 82
2021
Q1
$5.86M Buy
31,345
+769
+3% +$150K 0.22% 102
2020
Q4
$5.16M Sell
30,576
-2,801
-8% -$418K 0.21% 114
2020
Q3
$4.94M Buy
33,377
+1,977
+6% +$306K 0.23% 106
2020
Q2
$5.16M Buy
31,400
+14,197
+83% +$2.18M 0.28% 86
2020
Q1
$2.39M Buy
17,203
+1,483
+9% +$204K 0.16% 166
2019
Q4
$2.07M Buy
15,720
+750
+5% +$86.9K 0.11% 228
2019
Q3
$1.66M Hold
14,970
0.1% 264
2019
Q2
$1.66M Sell
14,970
-9,702
-39% -$1.14M 0.1% 264
2019
Q1
$3.2M Buy
24,672
+4,986
+25% +$606K 0.22% 117
2018
Q4
$2.28M Buy
19,686
+6,436
+49% +$719K 0.2% 124
2018
Q3
$1.42M Buy
13,250
+321
+2% +$32.1K 0.1% 261
2018
Q2
$1.23M Sell
12,929
-832
-6% -$68.3K 0.09% 289
2018
Q1
$1.06M Buy
13,761
+681
+5% +$54.8K 0.09% 319
2017
Q4
$1.1M Sell
13,080
-99
-0.8% -$8.42K 0.1% 288
2017
Q3
$1.13M Sell
13,179
-536
-4% -$44K 0.13% 206
2017
Q2
$1.13M Buy
13,715
+701
+5% +$57.2K 0.15% 188
2017
Q1
$1.09M Buy
+13,014
New +$1.04M 0.16% 160
2016
Q3
$621K Sell
7,740
-172
-2% -$13.8K 0.12% 245
2016
Q2
$623K Sell
7,912
-7,571
-49% -$570K 0.14% 195
2016
Q1
$1.11M Buy
15,483
+3,838
+33% +$290K 0.3% 72
2015
Q4
$981K Sell
11,645
-1,349
-10% -$112K 0.32% 74
2015
Q3
$1.09M Sell
12,994
-973
-7% -$82.1K 0.33% 57
2015
Q2
$1.18M Buy
13,967
+9
+0.1% +$686 0.35% 50
2015
Q1
$995K Buy
13,958
+130
+0.9% +$9.26K 0.27% 78
2014
Q4
$996K Sell
13,828
-239
-2% -$16.1K 0.31% 65
2014
Q3
$912K Buy
14,067
+265
+2% +$16.8K 0.33% 67
2014
Q2
$858K Buy
13,802
+1,077
+8% +$64.3K 0.36% 76
2014
Q1
$749K Buy
12,725
+324
+3% +$18.1K 0.39% 74
2013
Q4
$632K Buy
+12,401
New +$621K 0.32% 72

Other funds holding LLY

Advisory Services Network's LLY Position: Q1 2026 in Review

Advisory Services Network increased its Eli Lilly (LLY) stake by 0.21% in Q1 2026, buying an estimated $109K and bringing the position to 50,669 shares worth $46.6M. The position accounts for 0.62% of the portfolio, ranked #15.

Advisory Services Network first reported a position in LLY in Q4 2013 and has held it in 49 quarters since. The position peaked at $54.3M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Advisory Services Network held 50,669 shares of Eli Lilly worth $46.6M as of Q1 2026.
  • Advisory Services Network bought 108 Eli Lilly shares in Q1 2026, an estimated $109K.
  • Eli Lilly made up 0.62% of Advisory Services Network's portfolio in Q1 2026, its #15 holding.
  • Advisory Services Network first reported a position in Eli Lilly in Q4 2013 and has held it in 49 quarters since.
  • Advisory Services Network's Eli Lilly position peaked at $54.3M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.